The Global Point-of-Care Glucose Testing Market report from DataGuru Research Partners provides a detailed analysis of industry trends, size, share, and forecast from 2022 to 2031. Covering global, regional, and country-level insights, the report examines key market dynamics including drivers, restraints, and opportunities. It also includes competitive analysis, segment performance, technological advancements, and market growth projections driven by factors like rising diabetes prevalence, increased patient awareness, and technological improvements in glucose testing devices.

People with diabetes who are hospitalized have frequent fluctuations in blood sugar levels owing to illness, stress, dietary changes, and changes in medications and treatments. These changes need consistent testing so that the blood glucose can be regulated as much as possible. The American Diabetes Association recommends Point-of-Care Glucose testing for hospitalized persons with Diabetes. Point-of-Care Glucose Testing has evolved to become a valuable tool for millions of patients diagnosed with diabetes by providing immediate assessment. Companies operating in this market are focused on improving accuracy of devices by eliminating all sources of error.

Market Overview

The Global Point-of-Care Glucose Testing Market was valued at USD 3.32 Billion in 2023 and is estimated to reach at USD 4.54 Billion in 2031 growing at a CAGR of 4.0% over the forecast period from 2024-2031. The report would provide you with market size estimates both in terms of revenue (USD Billion) and volume (Billion Units) for the time period from 2023 to 2031. The report would provide various factors responsible for growth of the market across various geographies considered under the scope of the study. The report covers in-depth global and regional level analysis of various market segmentations based on Product Type, Portability, and Region.

Market Dynamics:

Below are the factors impacting the growth of Point-of-Care Glucose Testing Market:

• Rise in Diabetes Patients
  • According to International Diabetes Federation (IDF), the patients with diabetes will significantly increase in 2030 considering major life-style issues with reduced exercise and poor dietary habits leading to health conditions including diabetes.
• Increased awareness
  • Point-of-care glucose testing has evolved to become an effective diabetes management tool over the years. Patients have realized that it offers clinical, operational, and economic benefits to patients. Furthermore, with increasing disposable income of patients, the market for point-of-care glucose monitoring will grow.
• Improved convenience
  • Laboratories take time for testing as several lab assistants are involved to perform multiple tests thereby increasing the probability of pre and post analytical errors along with issues introduced during transportation and sample mixing process. Thus, point-of-care glucose testing decreases the total turnaround time and reduces patient’s stay at hospital.
• Technological advantages
  • Patients prefer point-of-care glucose testing because it is user-friendly thereby enabling operation even by nontechnical/non laboratory staff.

Regional Analysis

Based on region, Global Point-of-Care Glucose Testing Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America is divided into United States, Canada, and Mexico. Europe is bifurcated into Germany, U.K., France, Italy, Spain and Rest of Europe. The key countries covered under Asia Pacific region include China, Japan, India, South East Asia and Rest of Asia Pacific. Middle East & Africa is bifurcated into UAE, Saudi Arabia, South Africa and Rest of MEA. Finally, Latin America is divided into Brazil, Argentina and Rest of Latin America.

Competition Landscape

The report covers company profiles and competition analysis of major players operating under Global Point-of-Care Glucose Testing Market. The company profile section includes Company Overview, Financials, Business Overview, Recent Developments, Key Strategies, Product Mapping, Regional Presence, etc. Further, the competition analysis provides you with details about Competitor Overview, Market Share Analysis, Company Performance based on Various Parameters, etc. The major players operating in Global Point-of-Care Glucose Testing Market are F. Hoffmann-La Roche Ltd., Abbott, Nipro, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Nova Biomedical, ACON Laboratories, Trividia Health, Inc., Prodigy Diabetes Care, LLC, Bayer AG/Ascensia Diabetes Care Holdings AG, and EKF Diagnostics.

 Market Segmentation

The Global Point-of-Care Glucose Testing Market can be segmented on the basis of Product Type, Portability, and Region. Further, the report would provide a detailed analysis based on below mentioned market segmentation at the global as well regional levels.

Global Point-of-Care Glucose Testing Market Scope:

Global Point-of-Care Glucose Testing Market by, Region and Countries:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South East Asia
  • Rest of Asia Pacific
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
• South America
  • Brazil
  • Argentina
  • Rest of South America

Reason to Purchase the Report:

• Latest trends in the market
• In depth market segmentation and cross regional / country analysis
• Market dynamics analysis including drivers, restraints and opportunities in the market
• Market sizing and segment analysis
• Competition Analysis including profiling of key market players
• Market share analysis and key strategies adopted by key players
• Recent developments and technological advancement by key players in the market
• Key takeaways from the research findings to take strategic decision in business needs